EFX vs TECH
Equifax Inc (EFX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EFX and TECH stock pages for the full models.
Not investment advice.